PubRank

A Gompel

Author PubWeight™ 35.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hormonal contraception and risk of cancer. Hum Reprod Update 2010 1.69
2 Menopausal hot flushes and night sweats: where are we now? Climacteric 2011 1.61
3 Benefits of progestin contraception in non-allergic angioedema. Clin Exp Allergy 2013 1.49
4 Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol 2010 1.38
5 Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J Clin Endocrinol Metab 1986 1.18
6 Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. J Clin Endocrinol Metab 1999 1.15
7 Insulin resistance, obesity and breast cancer risk. Maturitas 2008 1.08
8 HRT in the early menopause: scientific evidence and common perceptions. Climacteric 2008 1.05
9 Type III hereditary angio-oedema: clinical and biological features in a French cohort. Allergy 2010 1.05
10 Prevention of diseases after menopause. Climacteric 2014 0.99
11 Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells. Int J Cancer 1996 0.95
12 Resistance to induced apoptosis in the human neuroblastoma cell line SK-N-SH in relation to neuronal differentiation. Role of Bcl-2 protein family. Eur J Biochem 2001 0.94
13 Estradiol/progesterone interaction in normal and pathologic breast cells. Ann N Y Acad Sci 1986 0.90
14 Tamoxifen and hydroxytamoxifen isomers versus estradiol effects on normal human breast cells in culture. Cancer Res 1988 0.90
15 Antiestrogen action of progesterone in breast tissue. Breast Cancer Res Treat 1986 0.89
16 Embryonic testicular regression syndrome and severe mental retardation in sibs. Ann Genet 1985 0.87
17 Pulmonary lymphangiomyomatosis. Follow-up and long-term outcome with antiestrogen therapy; a report of eight cases. Chest 1992 0.87
18 Oral progestagens before menopause and breast cancer risk. Br J Cancer 2007 0.85
19 Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells. J Steroid Biochem Mol Biol 1999 0.84
20 bcl-2 expression in normal breast tissue during the menstrual cycle. Int J Cancer 1994 0.84
21 Ovarian hyperthecosis on grayscale and color Doppler ultrasound. Ultrasound Obstet Gynecol 2008 0.82
22 Pre- and posttransplant glomerulonephritis in a case of sarcoidosis. Nephron 1983 0.80
23 Hormone therapy and breast cancer risk. Climacteric 2007 0.79
24 Ovarian failure with thalidomide treatment in complex aphthosis: comment on the concise communication by Ordi et al. Arthritis Rheum 1999 0.79
25 Fibrinogen and plasminogen modifications during oral estradiol replacement therapy. Fertil Steril 1997 0.78
26 Tamoxifen contraindicated in women with hereditary angioedema? Ann Oncol 2009 0.78
27 Estradiol stimulates c-myc proto-oncogene expression in normal human breast epithelial cells in culture. J Steroid Biochem Mol Biol 1995 0.78
28 Estradiol and progesterone receptors in cultured normal human breast epithelial cells and fibroblasts: immunocytochemical studies. J Clin Endocrinol Metab 1991 0.77
29 bcl-2 proto-oncogene, apoptosis and oncogenesis. Int J Oncol 1996 0.77
30 Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women. Am J Obstet Gynecol 1982 0.77
31 Contribution of plasma androstenedione to 5 alpha-androstanediol glucuronide in women with idiopathic hirsutism. J Clin Endocrinol Metab 1986 0.77
32 Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells. J Mol Endocrinol 2002 0.76
33 17 beta-Hydroxysteroid dehydrogenase activity in human breast epithelial cell and fibroblast cultures. Endocrinology 1984 0.76
34 Antiestrogen action of progesterone in breast tissue. Horm Res 1987 0.76
35 [Iatrogenic Cushing's syndrome caused by an acute overdose of triamcinolone]. Therapie 1987 0.75
36 Ovarian cancer and hormone replacement therapy. Lancet 2007 0.75
37 Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients. Clin Exp Immunol 2014 0.75
38 [Estradiol-progesterone interaction in normal and pathological human breast cells]. Ann Endocrinol (Paris) 1986 0.75
39 Risk of venous thromboembolism and oral contraceptives. Lancet 2002 0.75
40 Can we advise ovulation induction in patients with SLE? Scand J Rheumatol Suppl 1998 0.75
41 [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?]. Gynecol Obstet Fertil 2008 0.75
42 Effects of estradiol and promegestone on human breast cell cultures. An ultrastructural study. Pathol Res Pract 1986 0.75
43 Massive ovarian haemorrhage complicating oral anticoagulation in the antiphospholipid syndrome: a report of three cases. Lupus 1999 0.75
44 [Induction of ovulation by a luteinizing hormone releasing hormone pump. Principles, indications and results]. Presse Med 1985 0.75
45 [Pulsatile administration of GnRH: from the future to the present]. Ann Endocrinol (Paris) 1988 0.75
46 [Pulmonary lymphangiomyomatosis. Long-term benefit of anti-estrogen treatments remains uncertain]. Rev Pneumol Clin 1995 0.75
47 [Antiestrogens and normal human breast cell proliferation]. Ann Endocrinol (Paris) 1989 0.75
48 Spontaneous pregnancy in a woman with lupus and thyroiditis despite imminent premature ovarian failure. Ann Rheum Dis 2004 0.75
49 [Epithelial cells of normal human breast in culture. Ultrastructural aspects and changes under the effects of hormones (estradiol, prolactin)]. Arch Anat Cytol Pathol 1985 0.75
50 [Antiestrogen action of progesterone in the breast]. Pathol Biol (Paris) 1987 0.75
51 [Hormonal sterility caused by ovulation disorders]. Rev Prat 1983 0.75
52 Normal breast cells in culture. Effect of estrogens, progestins, and antiestrogens. Ann N Y Acad Sci 1990 0.75
53 [Hormone replacement therapy in menopause in question?]. Rev Med Interne 2000 0.75
54 [Hormones and lupus]. Rev Med Interne 1985 0.75
55 Bullous dermatosis associated with dysglobulinemia (two cases). Relationships with epidermolysis bullosa acquisita. Biomed Pharmacother 1982 0.75
56 [Hemoperitoneum of ovarian origin complicating antivitamin K treatment]. Rev Med Interne 2000 0.75
57 [Critical study of the treatment of Grave's disease (author's transl)]. Ann Med Interne (Paris) 1979 0.75
58 [Bladder endometriosis. Apropos of 4 cases and review of the literature]. Gynecol Obstet Fertil 2000 0.75
59 [Estroprogestational minipills: breast diseases and functional cysts of the ovary. Apropos of 87 cases]. Therapie 1985 0.75
60 [Secondary amenorrhea. Diagnostic approach]. Rev Prat 2000 0.75
61 [Thrombosis and assisted reproductive techniques (ART)]. J Mal Vasc 2011 0.75
62 [Hormone replacement therapy after endometrial or ovarian cancer]. Gynecol Obstet Fertil 2000 0.75
63 [Gonadoliberin. Therapeutic prospects]. Presse Med 1984 0.75
64 Hormone dependence of breast tissue estradiol and progesterone interaction. Int J Rad Appl Instrum B 1987 0.75
65 Therapeutic value and long-term safety of pulsed estrogen therapy. Maturitas 2001 0.75